Peptidoglycan Recognition Protein-S as a Dual-Action Antimicrobial and Immunomodulatory Agent Against Staphylococcus aureus
Probiotics and Antimicrobial Proteins · 2025
DOI: 10.1007/s12602-025-10845-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Probiotics and Antimicrobial Proteins, 2025. Verfasst von Priya Verma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India. Hauptthemen laut MEDLINE: Staphylococcus aureus, Anti-Bacterial Agents, Immunologic Factors, Milk. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
The global rise of multidrug-resistant (MDR) pathogens, particularly Staphylococcus aureus, necessitates the development of novel antimicrobial approaches. Peptidoglycan Recognition Protein-S (PGRP-S), an innate immune effector, is known to target bacterial cell walls by recognizing and hydrolyzing peptidoglycans. Camel (Camelus dromedarius) milk, renowned for its medicinal properties, is a rich source of PGRP-S and contributes to neonatal immunity. This study investigates the antimicrobial and immunomodulatory effects of camel milk-derived PGRP-S (C-PGRP-S) against S. aureus. Purified C-PGRP-S exhibited potent antibacterial activity, completely inhibiting bacterial growth at 40 μg/mL in MIC assays and demonstrating rapid bactericidal action in time-kill kinetics. Scanning electron microscopy revealed dose-dependent morphological damage to bacterial membranes. Immunologically, C-PGRP-S suppressed the overproduction of pro-inflammatory cytokines and restored ROS production in M1 macrophages significantly in infected cells. These results suggest that C-PGRP-S operates via a dual mechanism: direct bacterial lysis and immune modulation. Structural insights from the crystallographic model of camel PGRP-S (PDB ID: 3NW3) further highlight its molecular interaction with peptidoglycans. Taken together, C-PGRP-S emerges as a promising macromolecular therapeutic candidate, with potential as a natural alternative or adjunct to existing antibiotics in managing drug-resistant S. aureus infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biophysics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.
- Medical Oncology, All India Institute of Medical Sciences, New Delhi, 110029, India.
- National Research Centre On Camel, Bikaner, Rajasthan, 334001, India.
- Department of Biophysics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India. sujatasharma.aiims@gmail.com.
- Department of Biophysics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India. pradeepbdk@gmail.com.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Verma, P., Swaroop, P., Pandit, S., Prakash, V., Sharawat, S. K., Singh, T. P., Sharma, S., & Sharma, P. (2025). Peptidoglycan Recognition Protein-S as a Dual-Action Antimicrobial and Immunomodulatory Agent Against Staphylococcus aureus. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-025-10845-3
Vancouver
Verma P, Swaroop P, Pandit S, Prakash V, Sharawat SK, Singh TP, et al. Peptidoglycan Recognition Protein-S as a Dual-Action Antimicrobial and Immunomodulatory Agent Against Staphylococcus aureus. Probiotics and Antimicrobial Proteins. 2025. doi:10.1007/s12602-025-10845-3
BibTeX
@article{Verma2025,
author = {Verma, Priya and Swaroop, Priyanka and Pandit, Surabhi and Prakash, Ved and Sharawat, Surender Kumar and Singh, T P and Sharma, Sujata and Sharma, Pradeep},
title = {Peptidoglycan Recognition Protein-S as a Dual-Action Antimicrobial and Immunomodulatory Agent Against Staphylococcus aureus},
journal = {Probiotics and Antimicrobial Proteins},
year = {2025},
doi = {10.1007/s12602-025-10845-3}
}
EUVIMED